Knicks Power MSG Sports Toward Fourth Win in Five Sessions -- WSJ
Dow Jones2026/08/14 15:10By Shradha Dinesh
Madison Square Garden Sports is currently up more than 6% this week, marking its best weekly performance since May. Shares of the champion Knicks and Rangers owner have gained nearly 110% since this time last year and are up four of the past five days.
Record ticketing revenues from the NBA playoffs and highest-ever team merchandise sales clinched MSG Sports a 37% gain in revenue compared to the prior year quarter.
The company reported that per-game revenues during the playoffs averaged $20.2 million on a recent earnings call. MSG Sports expects nationwide demand for both teams to propel its FY27 growth; the recent championship series was the most watched NBA Finals in 28 years.
"Looking ahead to the upcoming seasons, we are off to a strong start with season ticket renewals. And we expect our combined season ticket renewal rate to once again reach levels above 90%," said Jamaal Lesane, chief operating officer at MSG Sports.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
August 14, 2026 11:10 ET (15:10 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
